Orbit Co-Invest I LLC 13D and 13G filings for RVL Pharmaceuticals plc:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-04-29 4:49 pm Sale | 2021-04-01 | 13G | RVL Pharmaceuticals plc RVLPQ | Orbit Co-Invest I LLC | 0 0.000% | -4,936,926 (Position Closed) | Filing |
| 2020-11-25 7:01 pm Purchase | 2020-11-20 | 13G | RVL Pharmaceuticals plc RVLPQ | Orbit Co-Invest I LLC | 4,936,926 7.900% | 4,936,926 (New Position) | Filing |